Synthesis of the Naturally Occurring (-)-1,3,5-Tri-O-Caffeoylquinic Acid

Overview

Journal Synlett

Specialty Chemistry

Date 2010 Feb 17

PMID 20157344

Citations 2

Authors

Kay M Brummond

Jolie E Deforrest

Affiliations

Soon will be listed here.

Abstract

Ribonuclease H (RNase H) is an essential component to the replication of human immunodeficiency virus (HIV), and only a few inhibitors of this enzyme are known. Millenia Hope Pharmaceuticals Inc. found that (-)-1,3,5-tri-O-caffeoylquinic acid is a potent RNase H inhibitor and antiviral agent. A facile route leading to this inhibitor from commercially available (-)-quinic acid is reported within.

Citing Articles

Risk Assessment of Chlorogenic and Isochlorogenic Acids in Coffee By-Products.

Behne S, Franke H, Schwarz S, Lachenmeier D Molecules. 2023; 28(14).

PMID: 37513412 PMC: 10385244. DOI: 10.3390/molecules28145540.

Advances in Production of Hydroxycinnamoyl-Quinic Acids: From Natural Sources to Biotechnology.

Valanciene E, Malys N Antioxidants (Basel). 2022; 11(12).

PMID: 36552635 PMC: 9774772. DOI: 10.3390/antiox11122427.

References

MacKay J, Bishop R, Rawal V . Rapid synthesis of the N-methylwelwitindolinone skeleton. Org Lett. 2005; 7(16):3421-4. DOI: 10.1021/ol051043t. View

Klumpp K, Mirzadegan T . Recent progress in the design of small molecule inhibitors of HIV RNase H. Curr Pharm Des. 2006; 12(15):1909-22. DOI: 10.2174/138161206776873653. View

Wang Z, Tu Y, Frohn M, Shi Y . A Dramatic pH Effect Leads to a Catalytic Asymmetric Epoxidation. J Org Chem. 1997; 62(8):2328-2329. DOI: 10.1021/jo962392r. View

Tramontano E . HIV-1 RNase H: recent progress in an exciting, yet little explored, drug target. Mini Rev Med Chem. 2006; 6(6):727-37. DOI: 10.2174/138955706777435733. View

Nicolaou K, Estrada A, Zak M, Lee S, Safina B . A mild and selective method for the hydrolysis of esters with trimethyltin hydroxide. Angew Chem Int Ed Engl. 2005; 44(9):1378-82. DOI: 10.1002/anie.200462207. View